Breaking News Instant updates and real-time market news.

ZTCOY

ZTE Corp.

$0.00

(0.00%)

, LITE

Lumentum

$44.73

1.29 (2.97%)

17:16
01/09/19
01/09
17:16
01/09/19
17:16

U.S., Israel discuss worries over China telecoms, Reuters reports

White House national security adviser John Bolton brought up U.S. concerns over the use of Chinese telecoms equipment in sensitive sectors during a weekend meeting with Benjamin Netanyahu, the prime minister of Israel, Reuters reports, citing a U.S. official. "We are all concerned about theft of intellectual property and Chinese telecoms companies that are being used by China for intelligence-gathering purposes," a senior administration official who was briefed on the talks told Reuters. The Trump administration has taken steps seeking to curtail market penetration by Huawei and ZTE Corp. (ZTCOY), two of China's largest network equipment makers. According to reports, Huawei accounted for nearly 17% of Lumentum's (LITE) sales in FY17, about 15% of FY17 sales for Oclaro (OCLR) and 11% of FY17 sales for Finisar (FNSR). The company competes in China with ZTE, Infinera (INFN) and Ciena (CIEN). Reference Link

ZTCOY

ZTE Corp.

$0.00

(0.00%)

LITE

Lumentum

$44.73

1.29 (2.97%)

OCLR

Bought by LITE

$0.00

(0.00%)

FNSR

Finisar

$21.39

0.01 (0.05%)

INFN

Infinera

$4.32

-0.07 (-1.59%)

CIEN

Ciena

$36.57

-0.08 (-0.22%)

  • 25

    Feb

ZTCOY ZTE Corp.
$0.00

(0.00%)

08/31/18
ROTH
08/31/18
NO CHANGE
Target $7
ROTH
Buy
Roth Capital encouraged by good reviews for Pixelworks-powered Axon 9
Roth Capital analyst Suji Desilva said he was encouraged by positive reviews for ZTE's (ZTCOY) Axon 9 smartphone, which uses Pixelworks' (PXLW) Iris mobile processor. Of note, reviews have emphasized the high aspect ratio OLED display and viewing quality, affirming his constructive thesis on the value of Pixelworks' core video technology, Desilva tells investors. He raised his price target on Pixelworks shares to $7 from $6 and maintains a Buy rating on the stock.
08/23/18
PIPR
08/23/18
UPGRADE
Target $26
PIPR
Overweight
Finisar upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray analyst Troy Jensen upgraded Finisar (FNSR) to Overweight from Neutral and raised his price target for the shares to $26 from $18. The shares closed yesterday down 95c, of 5%, to $18.65. China demand is returning via Huawei and ZTE (ZTCOY), Finisar is facing easy comps following five quarters of depressed demand and the upcoming 400G cycle should provide a tailwind in 2019, Jensen tells investors in a research note. On top of improving optical industry dynamics, the analyst believes Finisar's new CEO will improve the cost structure and execution at the company and drive better profitability. Now is a "great time" to revisit owning the shares, Jensen contends. The analyst this morning also upgraded Acacia Communications (ACIA) to Overweight from Neutral.
08/23/18
PIPR
08/23/18
UPGRADE
Target $46
PIPR
Overweight
Acacia Communications upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray analyst Troy Jensen upgraded Acacia Communications (ACIA) to Overweight and raised his price target for the shares to $46 from $38. Demand for optical is improving and Acacia is the best way to play the upcoming 400G cycle, Jensen tells investors in a research note. He believes the company's revenue growth will accelerate amid easy comps, improving demand from ZTE (ZTCOY), recent design wins and upcoming product cycles. Acacia can return to profitability levels seen before the China/ZTE slowdown, the analyst contends.
08/16/18
RILY
08/16/18
NO CHANGE
Target $50
RILY
Buy
Fabrinet price target raised to $50 from $40 at B. Riley FBR
B. Riley FBR analyst Dave Kang maintained a Buy rating on Fabrinet (FN) and raised his price target for shares to $50 from $40 ahead of the company's Q4 earnings on August 20, which he expects will be above consensus, as the latest industry data indicates that optical demand continues to improve after a 2017 correction. Kang says he remains a buyer into the print, and that Fabrinet should get a boost with the ban on ZTE (ZTCOY) lifted.
LITE Lumentum
$44.73

1.29 (2.97%)

12/17/18
NEED
12/17/18
NO CHANGE
Target $75
NEED
Strong Buy
Lumentum can continue posting 'beat and raise' quarters, says Needham
Needham analyst Alex Henderson left recent meetings with management with a "strong conviction" that Lumentum can continue to post "beat and raise" quarters. With the Oclaro deal closed, the analyst increased his estimates for Lumentum to reflect the combined company numbers. He believes the company looks well positioned and keeps a Strong Buy rating on the shares with a $75 price target.
12/18/18
NEED
12/18/18
NO CHANGE
Target $62
NEED
Buy
Fabrinet price target raised to $62 from $58 at Needham
Needham analyst Alex Henderson raised his price target on Fabrinet (FN) to $62 and kept his Buy, citing the recent commentary from Ciena (CIEN) regarding "strong optical demand" as well as his site visits to Lumentum (LITE) and NeoPhotonics (NPTN). The analyst believes that Fabrinet is "well positioned" as companies move out of China" and look for production alternatives, while its recent acquisitions in the optical space should "add business to Fabrinet". Henderson further notes that the global demand for optical products is looking "robust".
01/03/19
NEED
01/03/19
NO CHANGE
Target $65
NEED
Strong Buy
Lumentum price target lowered to $65 from $75 at Needham
Needham analyst N. Quinn Bolton lowered his price target on Lumentum (LITE) to $65 after the negative Q1 revenue pre-announcement from Apple (AAPL). The analyst says the reduction is intended to "de-risk" his forecasts on the company's 3D exposure to Apple, as he also lowers his 2019 3D sales forecast to $405M from $465M. Bolton is keeping his Strong Buy rating on the shares however, stating that excluding 3D, the company's "business looks strong with robust optical demand for ROADMs and Pumps and solid dynamics in Industrial lasers".
01/03/19
RILY
01/03/19
NO CHANGE
Target $62
RILY
Buy
B. Riley FBR an 'aggressive' buyer of Lumentum on today's selloff
B. Riley FBR analyst Dave Kang says he's an "aggressive" buyer today of Lumentum Holdings (LITE) on the selloff related to Apple's guidance cut last night. Apple weakness believe was already reflected in Lumentum's November preannouncement, Kang tells investors in a research note. He keeps a Buy rating on the shares with a $62 price target. The stock in early trading is down 8%, or $3.36, to $39.23.
OCLR Bought by LITE
$0.00

(0.00%)

11/12/18
CHLM
11/12/18
DOWNGRADE
Target $24
CHLM
Hold
Finisar downgraded to Hold from Buy at Craig-Hallum
Craig-Hallum analyst Richard Shannon downgraded Finisar (FNSR) to Hold from Buy and raised his price target on the shares to $24 from $23. The analyst believes that II-VI's (IIVI) $26/share cash and stock offer for the company, which was a 38% premium to the close on November 8th, is more than a fair deal, given that Lumentum's (LITE) offer premium for Oclaro (OCLR) earlier this year was 27%. Shannon has some doubts about whether this deal will close given the Lumentum/Oclaro deal has not yet closed and the intensifying political standoff between the US and China, but also admits II-VI and Finisar would not have agreed to this deal if there was not a good chance of closing.
11/13/18
PIPR
11/13/18
NO CHANGE
Target $72
PIPR
Overweight
Piper remains buyer of Lumentum following yesterday's 33% decline
Piper Jaffray analyst Troy Jensen remains a buyer of Lumentum (LITE) shares following yesterday's 33% decline. The reduced forecast at Apple (AAPL) has nothing to do with lost share for Lumentum, rather it is more indicative of lower sales forecasts at this key account, Jensen tells investors in a research note. The analyst continues to believe the 3D sensing market "will grow handsomely" with Apple and he notes that Android phones are just beginning their adoption. He also sees a pending opportunity for world facing 3D sensing applications. Further, the core telco optics market is in the early innings of an upgrade cycle, which should provide a "nice tailwind" for Lumentum, says Jensen. He also thinks the pending acquisition of Oclaro (OCLR) could also be a catalyst for the shares given the earnings accretion once the merger gets approval. The analyst lowered his price target for Lumentum to $72 from $85 and reiterates an Overweight rating on the name.
12/06/18
MKMP
12/06/18
DOWNGRADE
MKMP
Neutral
Finisar downgraded to Neutral from Buy at MKM Partners
MKM Partners analyst Michael Genovese downgraded Finisar (FNSR) to Neutral from Buy with a price target of $24 after its merger agreement with II-VI (IIVI) announced last month. The analyst further notes that Q4 is trending well for the optical components group which also includes Lumentum (LITE) and Oclaro (OCLR), but believes that the guidance for March will be "sequentially down due to annual price negotiations and Chinese New Year".
FNSR Finisar
$21.39

0.01 (0.05%)

12/18/18
LOOP
12/18/18
NO CHANGE
Target $23
LOOP
Hold
Finisar price target raised to $23 from $20 at Loop Capital
Loop Capital analyst James Kisner raised his price target on Finisar (FNSR) to $23, reflecting the "approximate value of the total consideration" that its shareholders will receive in the "very accretive" acquisition by II-VI Incorporated (IIVI). The analyst also lowers Finisar's FY20 EPS view to $1.06 from $1.71 and keeps his Hold rating on the stock, citing a "more conservative approach" in his forecasts for 3D sensing and "200G/400G datacom".
12/18/18
RILY
12/18/18
NO CHANGE
RILY
Luxtera buyout negative for Finisar, Applied Optoelectronics, says B. Riley FBR
B. Riley FBR analyst Dave Kang views Cisco Systems' (CSCO) acquisition of Luxtera as a negative for Finisar (FNSR) and Applied Optoelectronics (AAOI). The analyst has Neutral ratings on both stocks.
12/18/18
PIPR
12/18/18
NO CHANGE
PIPR
Cisco's Luxtera deal negative for Finisar and Applied Opto, says Piper Jaffray
Piper Jaffray analyst James Fish notes that the $660M acquisition of Luxterra announced by Cisco (CSCO) yesterday will have "mostly negative" impact on datacom focused optical transceiver suppliers Finisar (FNSR) and Applied Optoelectronics (AAOI). For the former, the analyst notes that Finisar generates about 75% of revenues from datacom transceivers and has frequently experienced Cisco as a 10% plus customer, adding that the vertical integration of the deal will diminishing Cisco's need for merchant transceivers. For the latter, the analyst notes that while Applied Optoelectronics does not "directly sell these components", the Luxterra deal shrinks its market and may lead to more aggressive price moves by the competitors. Fish also sees Fabrinet (FN) as a direct beneficiary of the Luxterra deal given its position as its contract manufacturer that stands to benefit "as Cisco ramps production of SiP transceivers."
12/31/18
12/31/18
UPGRADE
Target $40

Outperform
II-VI upgraded to Outperform on valuation at Northland
As previously reported, Northland upgraded II-VI (IIVI) to Outperform from Market Perform and increased its price target to $40 from $39. Analyst Tim Savageaux said the pullback in shares following the Finisar (FNSR) discounts an overly negative view given both pro forma earnings power and deal synergies of nearly $4/share.
INFN Infinera
$4.32

-0.07 (-1.59%)

11/09/18
JEFF
11/09/18
UPGRADE
Target $5
JEFF
Hold
Infinera upgraded to Hold from Underperform at Jefferies
Jefferies analyst George Notter upgraded Infinera to Hold while lowering his price target for the shares to $5 from $7.75. The analyst cites valuation for the upgrade following this week's post-earnings selloff.
11/13/18
MSCO
11/13/18
DOWNGRADE
Target $6
MSCO
Equal Weight
Infinera downgraded to Equal Weight from Overweight at Morgan Stanley
Morgan Stanley analyst Meta Marshall downgraded Infinera to Equal Weight and lowered his price target for the shares to $6 from $9.50.
11/13/18
MSCO
11/13/18
DOWNGRADE
Target $6
MSCO
Equal Weight
Infinera downgraded to Equal Weight after analyst day delay at Morgan Stanley
As previously reported, Morgan Stanley analyst Meta Marshall downgraded Infinera to Equal Weight from Overweight as she sees "no reason to race in" until there are signs that the revenue base has stabilized. The company's recent earnings report revealed that the Coriant business is in worse condition than expected, noted Marshall, who believes the company's postponement of its analyst day leaves few opportunities for a positive rerating in the next 6 months. Marshall lowered her price target on Infinera shares to $6.00 from $9.50 after lowering her 2021 EPS estimate to 40c-60c from the 75c-$1.00 she'd estimated earlier.
11/13/18
11/13/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Lumentum (LITE) downgraded to Neutral from Overweight at JPMorgan with analyst Samik Chatterjee saying yesterday's negative pronouncement underscored the challenges likely to be faced by Apple (AAPL) supply chain companies in delivering to investor expectations as Apple continues to prioritize its premium pricing strategy on iPhones relative to volumes. 2. Best Buy (BBY) downgraded to Neutral from Buy at BofA/Merrill with analyst Curtis Nagle citing expectations for slowing industry growth, difficult comps in key products and cost inflation. 3. Perrigo (PRGO) downgraded to Hold from Buy at Berenberg with analyst Patrick Trucchio saying although the key reason to own Perrigo shares remains intact, namely the U.S. government's push to shift more products from prescription to nonprescription, "too much uncertainty in generics has placed us on the sidelines." 4. Sabra Health Care (SBRA) downgraded to Neutral from Buy at Mizuho with analyst Richard Anderson saying he wants to a take a "pause" until the earnings reset from the "surprise news" of Senior Care stopping rent payments since May becomes better understood. 5. Infinera (INFN) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Meta Marshall saying she sees "no reason to race in" until there are signs that the revenue base has stabilized. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
CIEN Ciena
$36.57

-0.08 (-0.22%)

12/14/18
BMOC
12/14/18
NO CHANGE
Target $42
BMOC
Outperform
Ciena price target raised to $42 from $36 at BMO Capital
BMO Capital analyst Tim Long raised his price target on Ciena to $42 after its "strong" Q4 results that were driven by improving margins, saying the company continues to "diversify away from the traditional telco vertical into growth areas like webscale, where demand is strong. " The analyst also keeps his Outperform rating on Ciena while citing the company's "growth outlook, improving balance sheet, and consistent capital return program."
12/14/18
MKMP
12/14/18
NO CHANGE
Target $45
MKMP
Buy
Ciena price target raised to $45 from $38 at MKM Partners
MKM Partners analyst Michael Genovese raised his price target on Ciena to $45 after its "strong" Q4 results, saying the stock is a "must own" in the communications equipment sector. The analyst cites the company producing "another record quarter for orders, with book-to-bill well above 1.0", along with a 12% increase in its backlog in Q4, while its FY18 top-line grew by 10% in a market where revenues grew by mid-single digits. Genovese keeps his Buy rating on Ciena, stating that its market share gains are driven by its "best technology" and trust from its Tier 1 customers.
12/14/18
LOOP
12/14/18
DOWNGRADE
Target $36
LOOP
Hold
Ciena downgraded to Hold from Buy at Loop Capital
Loop Capital analyst James Kisner downgraded Ciena to Hold from Buy, stating that while its 2019 revenue guidance was above consensus he thinks the rest of guidance, with gross margin below consensus, implied roughly in-line Q1 EPS. He stills views the company as very well positioned in the optical systems market, but sees the stock as close to fully valued, Kisner tells investors. He maintains a $36 price target on Ciena shares.
12/14/18
ARGS
12/14/18
NO CHANGE
Target $42
ARGS
Buy
Ciena price target raised to $42 from $38 at Argus
Argus analyst James Kelleher raised his price target on Ciena to $42 and kept his Buy rating after its Q4 earnings beat and the management's guidance of at least 20% EPS growth over the next 3 years. The analyst notes that growth rate being "much faster than the historical trend and the outlook for its pees", adding that the company also has no "direct" exposure to the China slowdown as it looks to build market share profitably and with no pricing erosion.

TODAY'S FREE FLY STORIES

BDRBF

Bombardier

$0.00

(0.00%)

11:05
02/22/19
02/22
11:05
02/22/19
11:05
Hot Stocks
Bombardier to invest $22M in two aerospace research projects in Quebec »

Bombardier announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZG

Zillow

$40.94

5.87 (16.74%)

, Z

Zillow

$41.12

6.09 (17.39%)

11:03
02/22/19
02/22
11:03
02/22/19
11:03
Hot Stocks
Zillow adds to gain as Citron sets $70 target, turns positive after CEO change »

Shares of Zillow Group…

ZG

Zillow

$40.94

5.87 (16.74%)

Z

Zillow

$41.12

6.09 (17.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 28

    Feb

  • 05

    Mar

  • 06

    Mar

  • 07

    Mar

  • 11

    Mar

  • 25

    Mar

BECN

Beacon Roofing

$37.50

0.13 (0.35%)

11:02
02/22/19
02/22
11:02
02/22/19
11:02
Hot Stocks
Beacon Roofing announces departure of CEO Paul Isabella later this year »

Beacon Roofing Supply…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

C

Citi

$64.03

-0.28 (-0.44%)

11:00
02/22/19
02/22
11:00
02/22/19
11:00
Options
Active trading in Citigroup short-term puts »

Active trading in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 15

    Apr

  • 28

    May

  • 13

    Jul

ZG

Zillow

$40.54

5.47 (15.60%)

, Z

Zillow

$40.94

5.91 (16.87%)

10:57
02/22/19
02/22
10:57
02/22/19
10:57
Periodicals
Citron says now positive on Zillow, calls returning CEO a 'stud' »

Citron Research tweeted:…

ZG

Zillow

$40.54

5.47 (15.60%)

Z

Zillow

$40.94

5.91 (16.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 28

    Feb

  • 05

    Mar

  • 06

    Mar

  • 07

    Mar

  • 11

    Mar

  • 25

    Mar

ZG

Zillow

$40.54

5.47 (15.60%)

, Z

Zillow

$40.94

5.91 (16.87%)

10:57
02/22/19
02/22
10:57
02/22/19
10:57
Periodicals
Breaking Periodicals news story on Zillow, Zillow »

Citron Research turns…

ZG

Zillow

$40.54

5.47 (15.60%)

Z

Zillow

$40.94

5.91 (16.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 28

    Feb

  • 05

    Mar

  • 06

    Mar

  • 07

    Mar

  • 11

    Mar

  • 25

    Mar

PFE

Pfizer

$43.02

0.88 (2.09%)

10:55
02/22/19
02/22
10:55
02/22/19
10:55
Periodicals
Pfizer exec to host presidential fundraiser for Gillibrand campaign, CNBC says »

Pfizer's executive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 18

    May

PLNT

Planet Fitness

$59.40

1.14 (1.96%)

10:50
02/22/19
02/22
10:50
02/22/19
10:50
Options
Earnings hedge opened in Planet Fitness »

Earnings hedge opened in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

FDX

FedEx

$178.46

-3.82 (-2.10%)

, AMZN

Amazon.com

$1,625.63

5.79 (0.36%)

10:44
02/22/19
02/22
10:44
02/22/19
10:44
On The Fly
Stamps.com plummets after announcing discontinuation of USPS partnership »

Shares of Stamps.com…

FDX

FedEx

$178.46

-3.82 (-2.10%)

AMZN

Amazon.com

$1,625.63

5.79 (0.36%)

STMP

Stamps.com

$84.82

-113.26 (-57.18%)

UPS

UPS

$109.32

-2.44 (-2.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

  • 18

    Mar

  • 19

    Mar

  • 01

    Apr

  • 02

    Apr

TROX

Tronox

$11.80

0.45 (3.96%)

10:40
02/22/19
02/22
10:40
02/22/19
10:40
Options
Bullish call flow in Tronox ahead of earnings next week »

Bullish call flow in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

10:40
02/22/19
02/22
10:40
02/22/19
10:40
General news
Fed's Williams: the Phillips Curve is "alive and well" »

Fed's Williams: the…

C

Citi

$64.24

-0.07 (-0.11%)

, INTC

Intel

$52.73

1.33 (2.59%)

10:39
02/22/19
02/22
10:39
02/22/19
10:39
On The Fly
Citi, Intel upgrades, Roku, Nordstrom downgrades among today's top analyst calls »

Check out today's top…

C

Citi

$64.24

-0.07 (-0.11%)

INTC

Intel

$52.73

1.33 (2.59%)

ROKU

Roku

$59.51

8.04 (15.62%)

JWN

Nordstrom

$43.50

-0.97 (-2.18%)

KHC

Kraft Heinz

$34.95

-13.24 (-27.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 25

    Feb

  • 25

    Feb

  • 03

    Mar

  • 06

    Mar

  • 25

    Mar

  • 26

    Mar

  • 15

    Apr

  • 28

    May

  • 13

    Jul

EA

Electronic Arts

$93.86

-2.97 (-3.07%)

10:37
02/22/19
02/22
10:37
02/22/19
10:37
Periodicals
EA starts massive round of layoffs at Australian studio, Kotaku reports »

Electronic Arts has begun…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

PYX

Pyxus

$24.70

-1.46 (-5.58%)

10:36
02/22/19
02/22
10:36
02/22/19
10:36
Initiation
Pyxus initiated  »

Pyxus initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XRX

Xerox

$31.60

0.26 (0.83%)

10:30
02/22/19
02/22
10:30
02/22/19
10:30
Options
Downside hedge opened in Xerox April options »

Downside hedge opened in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

W

Wayfair

$149.39

32.25 (27.53%)

10:29
02/22/19
02/22
10:29
02/22/19
10:29
Recommendations
Wayfair analyst commentary  »

Wayfair price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 03

    Mar

10:26
02/22/19
02/22
10:26
02/22/19
10:26
General news
Stocks higher as trade talks continue »

Stock futures were higher…

ACER

Acer Therapeutics

$24.25

0.38 (1.59%)

10:25
02/22/19
02/22
10:25
02/22/19
10:25
Conference/Events
William Blair biotech analysts to hold an analyst/industry conference call »

Biotech Analysts, along…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 25

    Jun

AVEO

Aveo Pharmaceuticals

$0.62

0.0006 (0.10%)

, BMY

Bristol-Myers

$50.47

0.32 (0.64%)

10:25
02/22/19
02/22
10:25
02/22/19
10:25
Conference/Events
Piper Jaffray biotech analysts to hold an analyst/industry conference call »

Biotech Analysts, along…

AVEO

Aveo Pharmaceuticals

$0.62

0.0006 (0.10%)

BMY

Bristol-Myers

$50.47

0.32 (0.64%)

EXEL

Exelixis

$21.28

0.06 (0.28%)

IMMU

Immunomedics

$14.34

0.01 (0.07%)

JNJ

Johnson & Johnson

$135.83

0.43 (0.32%)

MRK

Merck

$80.55

0.73 (0.91%)

NKTR

Nektar

$40.10

-0.16 (-0.40%)

PFE

Pfizer

$42.89

0.75 (1.78%)

SGEN

Seattle Genetics

$69.99

0.74 (1.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 25

    Feb

  • 25

    Feb

  • 25

    Feb

  • 27

    Feb

  • 28

    Feb

  • 06

    Mar

  • 11

    Apr

  • 18

    May

  • 20

    May

  • 17

    Jun

10:25
02/22/19
02/22
10:25
02/22/19
10:25
Conference/Events
Cowen consumer analysts to hold an analyst/industry conference call »

Consumer Analysts Kernan…

XEC

Cimarex Energy

$73.78

0.45 (0.61%)

, REN

Resolute Energy

$31.93

0.41 (1.30%)

10:25
02/22/19
02/22
10:25
02/22/19
10:25
Conference/Events
Resolute Energy to host special shareholder meeting »

Special Shareholder…

XEC

Cimarex Energy

$73.78

0.45 (0.61%)

REN

Resolute Energy

$31.93

0.41 (1.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 04

    Mar

  • 22

    May

LKSD

LSC Communications

$9.20

-0.21 (-2.23%)

, QUAD

Quad/Graphics

$15.63

-0.165 (-1.04%)

10:25
02/22/19
02/22
10:25
02/22/19
10:25
Conference/Events
Quad/Graphics to host special shareholder meeting »

Special Shareholder…

LKSD

LSC Communications

$9.20

-0.21 (-2.23%)

QUAD

Quad/Graphics

$15.63

-0.165 (-1.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

QUAD

Quad/Graphics

$15.63

-0.165 (-1.04%)

, LKSD

LSC Communications

$9.20

-0.21 (-2.23%)

10:25
02/22/19
02/22
10:25
02/22/19
10:25
Conference/Events
LSC Communications to host special shareholder meeting »

Special Shareholder…

QUAD

Quad/Graphics

$15.63

-0.165 (-1.04%)

LKSD

LSC Communications

$9.20

-0.21 (-2.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

ELGX

Endologix

$0.54

0.0223 (4.27%)

10:25
02/22/19
02/22
10:25
02/22/19
10:25
Conference/Events
Endologix to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

  • 25

    Feb

ACAM

Acamar Partners

$0.00

(0.00%)

10:23
02/22/19
02/22
10:23
02/22/19
10:23
Syndicate
Acamar Partners opens at $10.01, IPO priced at $10.00 per share »

Acamar Partners (ACAM)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.